Core Viewpoint - The company has approved a comprehensive credit facility of up to 2 billion RMB to support its subsidiary, Fujian Huakang Pharmaceutical Co., Ltd, through various banks and financial institutions [1][2]. Group 1: Guarantee Details - The company has provided a total guarantee amount of 15 million RMB, leaving a remaining guarantee capacity of 65 million RMB as of the announcement date [2][4]. - Fujian Huakang is a wholly-owned subsidiary of the company, with the company holding 85% of its shares [3][4]. - The guarantee is aimed at meeting the operational needs of the subsidiary and is deemed to have low risk due to the company's control over the subsidiary [4]. Group 2: Financial Information - As of December 31, 2024, Fujian Huakang reported total assets of 58.23 million RMB, total liabilities of 34.01 million RMB, and net assets of 24.23 million RMB [2]. - As of March 31, 2025, Fujian Huakang's total assets increased to 61.10 million RMB, with total liabilities of 30.74 million RMB and net assets of 30.36 million RMB [3]. Group 3: Guarantee Agreement - The company signed a maximum guarantee contract with Xiamen Bank for a guarantee amount of 15 million RMB for Fujian Huakang [3][4]. - There are no associated guarantees or overdue guarantees reported [3][4].
诚意药业: 浙江诚意药业股份有限公司关于提供担保进展情况的公告